Treatments | N | pEC50 ± S.E. | GRE Activation | Enhancement | ||
---|---|---|---|---|---|---|
Glucocorticoid | β2-AdrenoceptorAgonist | |||||
M | -fold | -fold | ||||
Fluticasone | 18 | −8.69 ± 0.08 | 13.8 | |||
+Salmeterol | 6 | −8.74 ± 0.19 | 31.8** | 2.30 | ||
+ Formoterol | 6 | −8.70 ± 0.19 | 29.9* | 2.16 | ||
+Salbutamol | 6 | −8.65 ± 0.17 | 37.1** | 2.68 | ||
Budesonide | 17 | −8.65 ± 0.05 | 15.4 | |||
+Salmeterol | 6 | −8.56 ± 0.09 | 30.0* | 1.94 | ||
+ Formoterol | 6 | −8.57 ± 0.05 | 34.7* | 2.25 | ||
+Salbutamol | 5 | −8.54 ± 0.05 | 28.3*** | 1.84 | ||
Dexamethasone | 16 | −7.73 ± 0.07 | 14.5 | |||
+Salmeterol | 6 | −7.75 ± 0.11 | 34.4** | 2.38 | ||
+ Formoterol | 4 | −7.57 ± 0.10 | 37.7* | 2.61 | ||
| +Salbutamol | 6 | −7.60 ± 0.15 | 32.9* | 2.27 |